Filter
1699
Filtered Results: 1699
Text search:
J.
Smith
Featured
Recommendations
125
New Publications
268
Language
Document type
No document type
810
Studies & Reports
412
Guidelines
288
Manuals
97
Strategic & Response Plan
32
Fact sheets
29
Training Material
15
Situation Updates
6
Resource Platforms
4
Brochures
3
Infographics
3
Countries / Regions
Global
71
India
48
Western and Central Europe
40
South Africa
36
Russia
28
Latin America and the Carribbean
27
Africa
24
Brazil
23
Sierra Leone
18
Kenya
17
Liberia
17
Mozambique
16
Myanmar / Burma
16
Malawi
14
Zimbabwe
14
Germany
14
Eastern Europe
14
Argentina
13
Uganda
13
Indonesia
13
Ukraine
12
Tanzania
12
Ghana
11
Nigeria
11
Senegal
11
Congo, Democratic Republic of
11
Bangladesh
10
Ethiopia
10
Nepal
9
Philippines
9
Zambia
9
Cameroon
8
Syria
8
Burkina Faso
8
Guinea
8
Venezuela
8
South–East Asia Region
8
Middle East and North Africa
7
Lesotho
6
West and Central Africa
6
Spain
6
Rwanda
5
Asia
5
Eastern Europe and Central Asia
5
Paraguay
5
Jamaica
5
East and Southern Africa
5
Yemen
5
Colombia
4
Thailand
4
Benin
4
USA
4
Cambodia
4
North America
4
Pakistan
4
Chile
3
Haiti
3
Portugal
3
Southern Africa
3
Vietnam
3
Georgia
3
Angola
3
Botswana
3
South Sudan
3
North Macedonia
2
Mexico
2
China
2
Kyrgyzstan
2
Afghanistan
2
Peru
2
United Kingdom
2
Madagascar
2
Eswatini/ Swaziland
2
Canada
1
Singapore
1
Estonia
1
Burundi
1
Malaysia
1
Morocco
1
Italy
1
Armenia
1
Guinea-Bissau
1
Hungary
1
Jordan
1
Saudi Arabia
1
Western Pacific Region
1
Uruguay
1
Japan
1
Belgium
1
France
1
Norway
1
Belarus
1
Israel
1
Latvia
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Nicaragua
1
Sri Lanka
1
Namibia
1
Egypt
1
Sudan
1
Honduras
1
Mali
1
Chad
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
399
Clinical Guidelines
156
Public Health
116
Women & Child Health
84
Key Resources
52
Capacity Building
16
Pharmacy & Technologies
13
Toolboxes
Mental Health
232
COVID-19
197
HIV
147
Planetary Health
130
TB
117
Disability
65
Caregiver
64
NCDs
59
NTDs
57
AMR
43
Ebola & Marburg
36
Global Health Education
35
Rapid Response
32
Pharmacy
23
Conflict
23
Health Financing Toolbox
19
Refugee
17
Natural Hazards
14
Specific Hazards
12
Social Ethics
12
Zika
11
Polio
9
Cholera
3
COVID-19! How Can I Protect Myself and Others?
recommended
This curriculum will help you, and your community, understand the science of the virus that causes COVID-19 and other viruses like it. It will help you to figure out how this virus is impacting or affecting you or may impact you in the future. It will help you to understand the actions that you can ...
Air pollution is one of the leading causes of health complications and mortality worldwide, especially affecting lower-income groups, who tend to be more exposed and vulnerable. This study documents the relationship between ambient air pollution exposure and poverty in 211 countries and territories....
Lancet Glob Health 2022 Published Online May 24, 2022 https://doi.org/10.1016/S2214-109X(22)00185-1
Many commercial actors use a range of coordinated and sophisticated strategies to protect business interests— their corporate playbook—but many of these strategies come at the expense of public h...
Autres troubles
Chapitre H.5
Edition en français Traduction : Bojan Mirkovic Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA
Int. J. Environ. Res. Public Health 2018, 15(12), 2626; https://doi.org/10.3390/ijerph15122626
Climate change is increasing risks to human health and to the health systems that seek to protect the safety and well-being of populations. Health authorities require information about current associatio...
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May and June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA tea...
Curr HIV/AIDS Rep. 2022; 19(1): 37–45.
Published online 2022 Jan 29. doi: 10.1007/s11904-021-00589-4.
COVID-19 has had an unprecedented impact on the cascade-of-care among PLWH in LAC. There is a need for
longitudinal studies that assess clinic implication of these pandemic interactions in LAC.
Élément culturel important, les plantes ont été utilisées pendant des siècles par les populations pour se soigner. Cependant, peu d’ethnies connaissent leur pharmacopée de par le manque d’études ethnobotaniques. La présente étude, réalisée en pays San, entité territoriale traditionn...
A survival guide for clinicans.
3rd edition.
El plan de estudios le ayudará a usted, y a su comunidad, a entender la ciencia del virus que causa el COVID-19 y otros virus similares. Le ayudará a descubrir cómo este virus le afecta o puede afectarle en el futuro. Le ayudará a comprender las medidas que puede tomar para mantenerse a salvo y ...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
November 3, 2009https://doi.org/10.1371/journal.pmed.1000176
PLoS Med 6(11): e1000176. https://doi.org/10.1371/journal.pmed.1000176
In resource-limited countries, the number of available antiretroviral (ARV) drugs is relatively limited. Hence, caregivers face some caution and constraints in the changes of ARV treatment (ART) in people living with HIV (PLHIV). Our objective was to calculate the incidence, to describe the main cau...
In the Indian state of Bihar, visceral leishmaniasis (VL) is a major public health issue that has been aggravated by the rising incidence of new Human immunodeficiency virus (HIV) infections. In endemic areas, the risk of VL infections in patients living with HIV (PLHIV) is higher. It is important t...
Background: A recent report by the Institute for Health Metrics and Evaluation (IHME) highlights that mental health receives little attention despite being a major cause of disease burden. This paper extends previous assessments of development assistance for mental health (DAMH) in two significant w...
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp...
Globalization and Health (2021) 17:74 https://doi.org/10.1186/s12992-021-00722-3
SAJCC July 2011, Vol. 27, No. 1
